Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
DISC1 and PDE4B Are Interacting Genetic Factors in Schizophrenia That Regulate cAMP Signaling
J. Kirsty Millar,1*Benjamin S. Pickard,1*Shaun Mackie,1Rachel James,1Sheila Christie,1Sebastienne R. Buchanan,1M. Pat Malloy,1Jennifer E. Chubb,1Elaine Huston,2George S. Baillie,2Pippa A. Thomson,1Elaine V. Hill,2Nicholas J. Brandon,3Jean-Christophe Rain,4L. Miguel Camargo,3Paul J. Whiting,3Miles D. Houslay,2Douglas H. R. Blackwood,1,5Walter J. Muir,1,5David J. Porteous1
The disrupted in schizophrenia 1 (DISC1) gene is a candidatesusceptibility factor for schizophrenia, but its mechanisticrole in the disorder is unknown. Here we report that the geneencoding phosphodiesterase 4B (PDE4B) is disrupted by a balancedtranslocation in a subject diagnosed with schizophrenia anda relative with chronic psychiatric illness. The PDEs inactivateadenosine 3',5'-monophosphate (cAMP), a second messenger implicatedin learning, memory, and mood. We show that DISC1 interactswith the UCR2 domain of PDE4B and that elevation of cellularcAMP leads to dissociation of PDE4B from DISC1 and an increasein PDE4B activity. We propose a mechanistic model whereby DISC1sequesters PDE4B in resting cells and releases it in an activatedstate in response to elevated cAMP.
1 Medical Genetics Section, Molecular Medicine Centre, University of Edinburgh, Edinburgh EH4 2XU, UK. 2 Molecular Pharmacology Group, Division of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, Wolfson Building, University of Glasgow, Glasgow G12 8QQ, UK. 3 The Neuroscience Research Centre, Merck Sharp and Dohme, Ltd. (MSD), Terlings Park, Harlow, Essex, CM20 2QR, UK. 4 Hybrigenics S.A., 3-5 Impasse Reille75014 Paris, France. 5 Division of Psychiatry, University of Edinburgh, Royal Edinburgh Hospital, Edinburgh EH10 5HF, UK.
* These authors contributed equally to this work.
To whom correspondence should be addressed. E-mail: Kirsty.Millar{at}ed.ac.uk
The editors suggest the following Related Resources on Science sites:
In Science Magazine
PERSPECTIVES
Akira Sawa and Solomon H. Snyder (18 November 2005) Science310 (5751), 1128.
[DOI: 10.1126/science.1121114] |Summary »|Full Text »|PDF »
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Scents and Nonsense: Olfactory Dysfunction in Schizophrenia.
B. I. Turetsky, C.-G. Hahn, K. Borgmann-Winter, and P. J. Moberg (2009)
Schizophr Bull
35, 1117-1131
|Abstract »|Full Text »|PDF »
Understanding the Role of DISC1 in Psychiatric Disease and during Normal Development.
N. J. Brandon, J. K. Millar, C. Korth, H. Sive, K. K. Singh, and A. Sawa (2009)
J. Neurosci.
29, 12768-12775
|Abstract »|Full Text »|PDF »
DISC1 splice variants are upregulated in schizophrenia and associated with risk polymorphisms.
K. Nakata, B. K. Lipska, T. M. Hyde, T. Ye, E. N. Newburn, Y. Morita, R. Vakkalanka, M. Barenboim, Y. Sei, D. R. Weinberger, et al. (2009)
PNAS
106, 15873-15878
|Abstract »|Full Text »|PDF »
Towards a virtual fly brain.
J. D. Armstrong and J. I. van Hemert (2009)
Phil Trans R Soc A
367, 2387-2397
|Abstract »|Full Text »|PDF »
Mdm2 Directs the Ubiquitination of {beta}-Arrestin-sequestered cAMP Phosphodiesterase-4D5.
X. Li, G. S. Baillie, and M. D. Houslay (2009)
J. Biol. Chem.
284, 16170-16182
|Abstract »|Full Text »|PDF »
Arrestin Times for Developing Antipsychotics and {beta}-Blockers.
Disrupted-in-schizophrenia 1 and neuregulin 1 are required for the specification of oligodendrocytes and neurones in the zebrafish brain.
J. D. Wood, F. Bonath, S. Kumar, C. A. Ross, and V. T. Cunliffe (2009)
Hum. Mol. Genet.
18, 391-404
|Abstract »|Full Text »|PDF »
Strong Evidence for a Novel Schizophrenia Risk Locus on Chromosome 1p31.1 in Homogeneous Pedigrees From Tamil Nadu, India.
E. G. Holliday, D. R. Nyholt, S. Tirupati, S. John, P. Ramachandran, M. Ramamurti, A. J. Ramadoss, A. Jeyagurunathan, S. Kottiswaran, H. J. Smith, et al. (2009)
Am J Psychiatry
166, 206-215
|Abstract »|Full Text »|PDF »
An Odor-Specific Threshold Deficit Implicates Abnormal Intracellular Cyclic AMP Signaling in Schizophrenia.
Alternative Splicing, Methylation State, and Expression Profile of Tropomyosin-Related Kinase B in the Frontal Cortex of Suicide Completers.
C. Ernst, V. Deleva, X. Deng, A. Sequeira, A. Pomarenski, T. Klempan, N. Ernst, R. Quirion, A. Gratton, M. Szyf, et al. (2009)
Arch Gen Psychiatry
66, 22-32
|Abstract »|Full Text »|PDF »
Schizophrenia-Related Neural and Behavioral Phenotypes in Transgenic Mice Expressing Truncated Disc1.
S. Shen, B. Lang, C. Nakamoto, F. Zhang, J. Pu, S.-L. Kuan, C. Chatzi, S. He, I. Mackie, N. J. Brandon, et al. (2008)
J. Neurosci.
28, 10893-10904
|Abstract »|Full Text »|PDF »
Fault Diagnosis Engineering of Digital Circuits Can Identify Vulnerable Molecules in Complex Cellular Pathways.
A. Abdi, M. B. Tahoori, and E. S. Emamian (2008)
Science Signaling
1, ra10
|Abstract »|Full Text »|PDF »
Mice lacking the schizophrenia-associated protein FEZ1 manifest hyperactivity and enhanced responsiveness to psychostimulants.
N. Sakae, N. Yamasaki, K. Kitaichi, T. Fukuda, M. Yamada, H. Yoshikawa, T. Hiranita, Y. Tatsumi, J.-i. Kira, T. Yamamoto, et al. (2008)
Hum. Mol. Genet.
17, 3191-3203
|Abstract »|Full Text »|PDF »
Identification of YWHAE, a gene encoding 14-3-3epsilon, as a possible susceptibility gene for schizophrenia.
M. Ikeda, T. Hikita, S. Taya, J. Uraguchi-Asaki, K. Toyo-oka, A. Wynshaw-Boris, H. Ujike, T. Inada, K. Takao, T. Miyakawa, et al. (2008)
Hum. Mol. Genet.
17, 3212-3222
|Abstract »|Full Text »|PDF »
Molecular mechanisms of stress-induced prefrontal cortical impairment: Implications for mental illness.
A mutation in mouse Disc1 that models a schizophrenia risk allele leads to specific alterations in neuronal architecture and cognition.
M. Kvajo, H. McKellar, P. A. Arguello, L. J. Drew, H. Moore, A. B. MacDermott, M. Karayiorgou, and J. A. Gogos (2008)
PNAS
105, 7076-7081
|Abstract »|Full Text »|PDF »
Insolubility of Disrupted-in-Schizophrenia 1 Disrupts Oligomer-Dependent Interactions with Nuclear Distribution Element 1 and Is Associated with Sporadic Mental Disease.
S. R. Leliveld, V. Bader, P. Hendriks, I. Prikulis, G. Sajnani, J. R. Requena, and C. Korth (2008)
J. Neurosci.
28, 3839-3845
|Abstract »|Full Text »|PDF »
Disrupted in schizophrenia 1 and phosphodiesterase 4B: towards an understanding of psychiatric illness.
J. K. Millar, S. Mackie, S. J. Clapcote, H. Murdoch, B. S. Pickard, S. Christie, W. J. Muir, D. H. Blackwood, J. C. Roder, M. D. Houslay, et al. (2007)
J. Physiol.
584, 401-405
|Abstract »|Full Text »|PDF »
From the Cover: Dominant-negative DISC1 transgenic mice display schizophrenia-associated phenotypes detected by measures translatable to humans.
T. Hikida, H. Jaaro-Peled, S. Seshadri, K. Oishi, C. Hookway, S. Kong, D. Wu, R. Xue, M. Andrade, S. Tankou, et al. (2007)
PNAS
104, 14501-14506
|Abstract »|Full Text »|PDF »
Catecholamine and Second Messenger Influences on Prefrontal Cortical Networks of "Representational Knowledge": A Rational Bridge between Genetics and the Symptoms of Mental Illness.
Isoform-Selective Susceptibility of DISC1/Phosphodiesterase-4 Complexes to Dissociation by Elevated Intracellular cAMP Levels.
H. Murdoch, S. Mackie, D. M. Collins, E. V. Hill, G. B. Bolger, E. Klussmann, D. J. Porteous, J. K. Millar, and M. D. Houslay (2007)
J. Neurosci.
27, 9513-9524
|Abstract »|Full Text »|PDF »
PDE4B5, a Novel, Super-Short, Brain-Specific cAMP Phosphodiesterase-4 Variant Whose Isoform-Specifying N-Terminal Region Is Identical to That of cAMP Phosphodiesterase-4D6 (PDE4D6).
Y.-F. Cheung, Z. Kan, P. Garrett-Engele, I. Gall, H. Murdoch, G. S. Baillie, L. M. Camargo, J. M. Johnson, M. D. Houslay, and J. C. Castle (2007)
J. Pharmacol. Exp. Ther.
322, 600-609
|Abstract »|Full Text »|PDF »
p75 neurotrophin receptor regulates tissue fibrosis through inhibition of plasminogen activation via a PDE4/cAMP/PKA pathway.
B. D. Sachs, G. S. Baillie, J. R. McCall, M. A. Passino, C. Schachtrup, D. A. Wallace, A. J. Dunlop, K. F. MacKenzie, E. Klussmann, M. J. Lynch, et al. (2007)
J. Cell Biol.
177, 1119-1132
|Abstract »|Full Text »|PDF »
Genome-wide expression profiling of lymphoblastoid cell lines distinguishes different forms of autism and reveals shared pathways.
Y. Nishimura, C. L. Martin, A. Vazquez-Lopez, S. J. Spence, A. I. Alvarez-Retuerto, M. Sigman, C. Steindler, S. Pellegrini, N. C. Schanen, S. T. Warren, et al. (2007)
Hum. Mol. Genet.
16, 1682-1698
|Abstract »|Full Text »|PDF »
cAMP-Specific Phosphodiesterase-4 Enzymes in the Cardiovascular System: A Molecular Toolbox for Generating Compartmentalized cAMP Signaling.
M. D. Houslay, G. S. Baillie, and D. H. Maurice (2007)
Circ. Res.
100, 950-966
|Abstract »|Full Text »|PDF »
Families with the risk allele of DISC1 reveal a link between schizophrenia and another component of the same molecular pathway, NDE1.
W. Hennah, L. Tomppo, T. Hiekkalinna, O. M. Palo, H. Kilpinen, J. Ekelund, A. Tuulio-Henriksson, K. Silander, T. Partonen, T. Paunio, et al. (2007)
Hum. Mol. Genet.
16, 453-462
|Abstract »|Full Text »|PDF »
The Trypanosoma brucei cAMP phosphodiesterases TbrPDEB1 and TbrPDEB2: flagellar enzymes that are essential for parasite virulence.
M. Oberholzer, G. Marti, M. Baresic, S. Kunz, A. Hemphill, and T. Seebeck (2007)
FASEB J
21, 720-731
|Abstract »|Full Text »|PDF »
Schizophrenia: a common disease caused by multiple rare alleles.
J. M. McClellan, E. Susser, and M.-C. King (2007)
The British Journal of Psychiatry
190, 194-199
|Abstract »|Full Text »|PDF »
DISC1 Regulates Neurotrophin-Induced Axon Elongation via Interaction with Grb2.
T. Shinoda, S. Taya, D. Tsuboi, T. Hikita, R. Matsuzawa, S. Kuroda, A. Iwamatsu, and K. Kaibuchi (2007)
J. Neurosci.
27, 4-14
|Abstract »|Full Text »|PDF »
DISC1 Regulates the Transport of the NUDEL/LIS1/14-3-3{varepsilon} Complex through Kinesin-1.
S. Taya, T. Shinoda, D. Tsuboi, J. Asaki, K. Nagai, T. Hikita, S. Kuroda, K. Kuroda, M. Shimizu, S. Hirotsune, et al. (2007)
J. Neurosci.
27, 15-26
|Abstract »|Full Text »|PDF »
Schizophrenia in Translation: Disrupted in Schizophrenia (DISC1): Integrating Clinical and Basic Findings.
Compartmentalization of cAMP-Dependent Signaling by Phosphodiesterase-4D Is Involved in the Regulation of Vasopressin-Mediated Water Reabsorption in Renal Principal Cells.
E. Stefan, B. Wiesner, G. S. Baillie, R. Mollajew, V. Henn, D. Lorenz, J. Furkert, K. Santamaria, P. Nedvetsky, C. Hundsrucker, et al. (2007)
J. Am. Soc. Nephrol.
18, 199-212
|Abstract »|Full Text »|PDF »
DISC1-NDEL1/NUDEL protein interaction, an essential component for neurite outgrowth, is modulated by genetic variations of DISC1.
A. Kamiya, T. Tomoda, J. Chang, M. Takaki, C. Zhan, M. Morita, M. B. Cascio, S. Elashvili, H. Koizumi, Y. Takanezawa, et al. (2006)
Hum. Mol. Genet.
15, 3313-3323
|Abstract »|Full Text »|PDF »
Impact of the DISC1 Ser704Cys polymorphism on risk for major depression, brain morphology and ERK signaling.
R. Hashimoto, T. Numakawa, T. Ohnishi, E. Kumamaru, Y. Yagasaki, T. Ishimoto, T. Mori, K. Nemoto, N. Adachi, A. Izumi, et al. (2006)
Hum. Mol. Genet.
15, 3024-3033
|Abstract »|Full Text »|PDF »
Helix-1 of the cAMP-specific phosphodiesterase PDE4A1 regulates its phospholipase-D-dependent redistribution in response to release of Ca2+.
E. Huston, I. Gall, T. M. Houslay, and M. D. Houslay (2006)
J. Cell Sci.
119, 3799-3810
|Abstract »|Full Text »|PDF »
Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use.
Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia.
L. Georgieva, V. Moskvina, T. Peirce, N. Norton, N. J. Bray, L. Jones, P. Holmans, S. MacGregor, S. Zammit, J. Wilkinson, et al. (2006)
PNAS
103, 12469-12474
|Abstract »|Full Text »|PDF »
Schizophrenia Susceptibility Genes: Emergence of Positional Candidates and Future Directions.
A Primary Candidate Gene for Obsessive-compulsive Disorder..
J. F. Leckman and Y.-S. Kim (2006)
Arch Gen Psychiatry
63, 717-720
|Full Text »|PDF »
Genes and Schizophrenia: Beyond Schizophrenia: The Role of DISC1 in Major Mental Illness.
W. Hennah, P. Thomson, L. Peltonen, and D. Porteous (2006)
Schizophr Bull
32, 409-416
|Abstract »|Full Text »|PDF »
Chromosomal abnormalities and psychosis.
W. J. MUIR, B. S. PICKARD, and D. H. R. BLACKWOOD (2006)
The British Journal of Psychiatry
188, 501-503
|Abstract »|Full Text »|PDF »
Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs.
B. K. Lipska, T. Peters, T. M. Hyde, N. Halim, C. Horowitz, S. Mitkus, C. S. Weickert, M. Matsumoto, A. Sawa, R. E. Straub, et al. (2006)
Hum. Mol. Genet.
15, 1245-1258
|Abstract »|Full Text »|PDF »
Lessons from studying monogenic disease for common disease..
L. Peltonen, M. Perola, J. Naukkarinen, and A. Palotie (2006)
Hum. Mol. Genet.
15, R67-R74
|Full Text »|PDF »
Disc1 is mutated in the 129S6/SvEv strain and modulates working memory in mice.
H. Koike, P. A. Arguello, M. Kvajo, M. Karayiorgou, and J. A. Gogos (2006)
PNAS
103, 3693-3697
|Abstract »|Full Text »|PDF »